Arrow Pressure Injectable Picc
510(k) K061289
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK061289 | Date24 Aug 2006 | StatusActive |
Recalls
-
- Terminated Z-1255-2020
Product lidstock contains the incorrect expiration date for the product
-
- Terminated Z-2020-2018
Product sterility may be compromised due to unsealed packaging.
-
- Terminated Z-1325-2018
Certain lots of cardiovascular catheters may not be completely sealed and so sterility of the product cannot be guaranteed.
-
- Terminated Z-2338-2017
The Arrow Pressure Injectable PICC is intended for short-term or long-term peripheral access to the central venous system for intravenous therapy and blood sampling.
-
- Terminated Z-2772-2016
- Terminated Z-2774-2016
- Terminated Z-2771-2016
- Terminated Z-2773-2016
Notification of component molding abnormality by supplier used to package certain Arrow Select Kit (ASK) products.
-
- Terminated Z-0127-2016
Labeling inaccuracy in the Instructions for Use (IFU) and Patient Card. The IFU and Patient Card with these products state the PICC can withstand up to ten (10) pressure injections, however, the PICC has only been tested to withstand five (5) pressure injections.
-
- Terminated Z-2462-2015
the catheter peel-away component hub tabs may prematurely detach. One injury reported.
-
- Terminated Z-1682-2010
Tight fit in sheath. Arrow has received complaints of the PICC catheter fitting too tightly in the "kit supplied" peelable sheath. In some cases, clinicians have been unable to insert the catheter through the peelable sheath during the insertion procedure. If the catheter will not pass through the sheath, the clinician is required to place a guide wire back into the sheath, remove the sheath, a
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LJS
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.5970
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent